Skip to main content
TipRanks
Go Ultimate75% OFF

Vaccinex (VCNX) Ratios

304 Followers

Vaccinex Ratios

VCNX's free cash flow for Q4 2024 was $-3.93M. For the 2024 fiscal year, VCNX's free cash flow was increased by $0.00 and operating cash flow was $-3.93M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio0.450.500.572.954.17
Quick Ratio0.450.500.572.954.17
Cash Ratio0.040.220.262.523.81
Solvency Ratio-0.56-3.65-3.39-7.01-9.14
Operating Cash Flow Ratio-1.67-3.18-2.91-7.52-11.21
Short-Term Operating Cash Flow Coverage0.00-647.44-229.79-257.76-341.86
Net Current Asset Value$ -7.63M$ -2.55M$ -2.59M$ 4.69M$ 6.97M
Leverage Ratios
Debt-to-Assets Ratio3.070.010.070.060.04
Debt-to-Equity Ratio-0.73-0.01-0.110.090.05
Debt-to-Capital Ratio-2.66-0.01-0.120.090.05
Long-Term Debt-to-Capital Ratio-2.660.00-0.010.020.02
Financial Leverage Ratio-0.24-1.04-1.571.541.33
Debt Service Coverage Ratio-39.37-686.59-259.84-257.97-24.24
Interest Coverage Ratio-39.64-9367.50-22885.00-9953.00-27.80
Debt to Market Cap1.910.010.020.010.01
Interest Debt Per Share2.110.010.532.418.78
Net Debt to EBITDA-1.030.060.070.300.38
Profitability Margins
Gross Profit Margin98.33%100.00%100.00%68.00%81.22%
EBIT Margin-249.74%-3100.17%-3485.44%-19813.00%-2396.78%
EBITDA Margin-248.07%-3084.53%-3464.56%-19606.00%-2378.00%
Operating Profit Margin-249.74%-3117.30%-4014.91%-19906.00%-2498.89%
Pretax Profit Margin-251.07%-3100.50%-3552.81%-19815.00%-2486.67%
Net Profit Margin-251.07%-3100.50%-3552.81%-19722.00%-2486.67%
Continuous Operations Profit Margin-251.07%-3100.50%-3552.81%-19815.00%-2486.67%
Net Income Per EBT100.00%100.00%100.00%99.53%100.00%
EBT Per EBIT100.54%99.46%88.49%99.54%99.51%
Return on Assets (ROA)-292.38%-717.80%-557.73%-247.24%-227.37%
Return on Equity (ROE)69.29%748.95%876.29%-379.78%-301.94%
Return on Capital Employed (ROCE)252.27%753.01%1001.53%-365.92%-296.43%
Return on Invested Capital (ROIC)252.27%760.66%1108.77%-350.58%-288.26%
Return on Tangible Assets-292.38%-717.80%-557.73%-247.24%-227.37%
Earnings Yield-181.96%-905.90%-472.70%-72.61%-75.00%
Efficiency Ratios
Receivables Turnover1.810.720.590.570.00
Payables Turnover0.010.000.000.140.16
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover53.729.252.020.202.05
Asset Turnover1.160.230.160.010.09
Working Capital Turnover Ratio-0.90-0.230.480.020.34
Cash Conversion Cycle-35965.06508.94615.38-2037.92-2291.51
Days of Sales Outstanding201.23508.94615.38638.750.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding36166.290.000.002676.672291.51
Operating Cycle201.23508.94615.38638.750.00
Cash Flow Ratios
Operating Cash Flow Per Share-2.41-7.71-37.17-94.39-185.16
Free Cash Flow Per Share-2.41-7.72-37.31-94.88-185.39
Dividend Paid and CapEx Coverage Ratio-716.67-735.73-257.22-192.67-790.56
Capital Expenditure Coverage Ratio-716.67-735.73-257.22-192.67-790.56
Operating Cash Flow Coverage Ratio-1.17-647.44-69.77-39.33-64.87
Operating Cash Flow to Sales Ratio-3.08-26.93-30.24-190.74-28.11
Free Cash Flow Yield-223.44%-787.96%-403.84%-70.59%-84.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.55-0.11-0.21-1.38-1.33
Price-to-Sales (P/S) Ratio1.383.427.52271.6033.16
Price-to-Book (P/B) Ratio-0.38-0.83-1.855.234.03
Price-to-Free Cash Flow (P/FCF) Ratio-0.45-0.13-0.25-1.42-1.18
Price-to-Operating Cash Flow Ratio-0.45-0.13-0.25-1.42-1.18
Price-to-Earnings Growth (PEG) Ratio0.010.000.000.030.03
Enterprise Value Multiple-1.59-0.05-0.15-1.08-1.01
Enterprise Value8.27M974.97K3.00M21.25M21.64M
EV to EBITDA-1.59-0.05-0.15-1.08-1.01
EV to Sales3.951.625.26212.5424.05
EV to Free Cash Flow-1.28-0.06-0.17-1.11-0.85
EV to Operating Cash Flow-1.28-0.06-0.17-1.11-0.86
Tangible Book Value Per Share-2.84-1.19-4.9825.7054.25
Shareholders’ Equity Per Share-2.84-1.19-4.9825.7054.25
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.780.291.230.496.59
Net Income Per Share-1.97-8.88-43.68-97.59-163.80
Tax Burden1.001.001.001.001.00
Interest Burden1.011.001.021.001.04
Research & Development to Revenue2.0120.8729.08139.7919.07
SG&A to Revenue1.4711.3012.0762.026.92
Stock-Based Compensation to Revenue0.000.570.835.450.60
Income Quality1.230.870.850.961.13

Currency in USD